Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Aug 30, 2024

SELL
$28.89 - $35.33 $8,695 - $10,634
-301 Reduced 0.72%
41,395 $1.45 Billion
Q3 2021

Aug 30, 2024

SELL
$35.66 - $42.94 $4,457 - $5,367
-125 Reduced 0.3%
41,696 $1.53 Billion
Q2 2021

Aug 30, 2024

BUY
$23.7 - $39.27 $991,157 - $1.64 Million
41,821 New
41,821 $1.64 Billion
Q1 2021

Aug 30, 2024

BUY
$27.01 - $36.8 $123,570 - $168,360
4,575 Added 19.0%
28,654 $809 Million
Q4 2020

Aug 30, 2024

SELL
$27.51 - $34.36 $13,287 - $16,595
-483 Reduced 1.97%
24,079 $771 Million
Q3 2020

Aug 30, 2024

BUY
$25.8 - $34.61 $633,699 - $850,090
24,562 New
24,562 $793 Million

Others Institutions Holding HCM

About HUTCHMED (China) Ltd


  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $2.47B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.